TNFRSF11A and cancer: Receptor activator of NF-κB ligand (RANKL)–RANK signaling has many crucial physiological roles in bone and other tissues (Hanada et al. 2009), and aberrant RANKL–RANK signaling in cancer and bone cells affects cancer bone colonization (Dougall 2011).